ESLAW
Estrella Immunopharma, Inc.
Set alert
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.11
- Prev close
- 0.0701
- Mkt cap
- 22.23M
- Vol
- 4.30K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0701
- High
- 0.0701
- Forward P/E
- 0.00
- Beta
- -0.09
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- -0.09
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 2.81M
- Total cash
- 2.48M
- Total debt
- 22.00K
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
About Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- estrellabio.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on ESLAW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Highbridge Capital Management, LLC. | 20.82% | 416,495 | 38.27K | Sep 29, 2024 |
| Boothbay Fund Management, LLC | 9.49% | 189,899 | 17.45K | Sep 29, 2024 |
| ATW Spac Management LLC | 9.15% | 183,099 | 16.83K | Sep 29, 2024 |
| Shaw D.E. & Co., Inc. | 4.38% | 87,500 | 8.04K | Sep 29, 2024 |
| Walleye Capital LLC | 3.31% | 66,112 | 6.08K | Sep 29, 2024 |
| SkyView Investment Advisors, LLC | 3.13% | 62,500 | 5.74K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Investment Managers Ser Tr-Robinson Opportunistic Income Fd | 0.59% | 11,805 | 1.08K | Sep 29, 2024 |